List of Chapters/Sections(Table Of Content)
1 Study Coverage
1.1 Enzalutamide API Product Introduction
1.2 Market by Type
1.2.1 Global Enzalutamide API Market Size by Type, 2017 VS 2021 VS 2028
1.2.2 Purity?98%
1.2.3 Purity<98%
1.3 Market by Application
1.3.1 Global Enzalutamide API Market Size by Application, 2017 VS 2021 VS 2028
1.3.2 Enzalutamide Capsules
1.3.3 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Enzalutamide API Production
2.1 Global Enzalutamide API Production Capacity (2017-2028)
2.2 Global Enzalutamide API Production by Region: 2017 VS 2021 VS 2028
2.3 Global Enzalutamide API Production by Region
2.3.1 Global Enzalutamide API Historic Production by Region (2017-2022)
2.3.2 Global Enzalutamide API Forecasted Production by Region (2023-2028)
2.4 Europe
2.5 China
2.6 China Taiwan
2.7 India
3 Global Enzalutamide API Sales in Volume & Value Estimates and Forecasts
3.1 Global Enzalutamide API Sales Estimates and Forecasts 2017-2028
3.2 Global Enzalutamide API Revenue Estimates and Forecasts 2017-2028
3.3 Global Enzalutamide API Revenue by Region: 2017 VS 2021 VS 2028
3.4 Global Enzalutamide API Sales by Region
3.4.1 Global Enzalutamide API Sales by Region (2017-2022)
3.4.2 Global Sales Enzalutamide API by Region (2023-2028)
3.5 Global Enzalutamide API Revenue by Region
3.5.1 Global Enzalutamide API Revenue by Region (2017-2022)
3.5.2 Global Enzalutamide API Revenue by Region (2023-2028)
3.6 North America
3.7 Europe
3.8 Asia-Pacific
3.9 Latin America
3.10 Middle East & Africa
4 Competition by Manufactures
4.1 Global Enzalutamide API Production Capacity by Manufacturers
4.2 Global Enzalutamide API Sales by Manufacturers
4.2.1 Global Enzalutamide API Sales by Manufacturers (2017-2022)
4.2.2 Global Enzalutamide API Sales Market Share by Manufacturers (2017-2022)
4.2.3 Global Top 10 and Top 5 Largest Manufacturers of Enzalutamide API in 2021
4.3 Global Enzalutamide API Revenue by Manufacturers
4.3.1 Global Enzalutamide API Revenue by Manufacturers (2017-2022)
4.3.2 Global Enzalutamide API Revenue Market Share by Manufacturers (2017-2022)
4.3.3 Global Top 10 and Top 5 Companies by Enzalutamide API Revenue in 2021
4.4 Global Enzalutamide API Sales Price by Manufacturers
4.5 Analysis of Competitive Landscape
4.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
4.5.2 Global Enzalutamide API Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.5.3 Global Enzalutamide API Manufacturers Geographical Distribution
4.6 Mergers & Acquisitions, Expansion Plans
5 Market Size by Type
5.1 Global Enzalutamide API Sales by Type
5.1.1 Global Enzalutamide API Historical Sales by Type (2017-2022)
5.1.2 Global Enzalutamide API Forecasted Sales by Type (2023-2028)
5.1.3 Global Enzalutamide API Sales Market Share by Type (2017-2028)
5.2 Global Enzalutamide API Revenue by Type
5.2.1 Global Enzalutamide API Historical Revenue by Type (2017-2022)
5.2.2 Global Enzalutamide API Forecasted Revenue by Type (2023-2028)
5.2.3 Global Enzalutamide API Revenue Market Share by Type (2017-2028)
5.3 Global Enzalutamide API Price by Type
5.3.1 Global Enzalutamide API Price by Type (2017-2022)
5.3.2 Global Enzalutamide API Price Forecast by Type (2023-2028)
6 Market Size by Application
6.1 Global Enzalutamide API Sales by Application
6.1.1 Global Enzalutamide API Historical Sales by Application (2017-2022)
6.1.2 Global Enzalutamide API Forecasted Sales by Application (2023-2028)
6.1.3 Global Enzalutamide API Sales Market Share by Application (2017-2028)
6.2 Global Enzalutamide API Revenue by Application
6.2.1 Global Enzalutamide API Historical Revenue by Application (2017-2022)
6.2.2 Global Enzalutamide API Forecasted Revenue by Application (2023-2028)
6.2.3 Global Enzalutamide API Revenue Market Share by Application (2017-2028)
6.3 Global Enzalutamide API Price by Application
6.3.1 Global Enzalutamide API Price by Application (2017-2022)
6.3.2 Global Enzalutamide API Price Forecast by Application (2023-2028)
7 North America
7.1 North America Enzalutamide API Market Size by Type
7.1.1 North America Enzalutamide API Sales by Type (2017-2028)
7.1.2 North America Enzalutamide API Revenue by Type (2017-2028)
7.2 North America Enzalutamide API Market Size by Application
7.2.1 North America Enzalutamide API Sales by Application (2017-2028)
7.2.2 North America Enzalutamide API Revenue by Application (2017-2028)
7.3 North America Enzalutamide API Sales by Country
7.3.1 North America Enzalutamide API Sales by Country (2017-2028)
7.3.2 North America Enzalutamide API Revenue by Country (2017-2028)
7.3.3 U.S.
7.3.4 Canada
8 Europe
8.1 Europe Enzalutamide API Market Size by Type
8.1.1 Europe Enzalutamide API Sales by Type (2017-2028)
8.1.2 Europe Enzalutamide API Revenue by Type (2017-2028)
8.2 Europe Enzalutamide API Market Size by Application
8.2.1 Europe Enzalutamide API Sales by Application (2017-2028)
8.2.2 Europe Enzalutamide API Revenue by Application (2017-2028)
8.3 Europe Enzalutamide API Sales by Country
8.3.1 Europe Enzalutamide API Sales by Country (2017-2028)
8.3.2 Europe Enzalutamide API Revenue by Country (2017-2028)
8.3.3 Germany
8.3.4 France
8.3.5 U.K.
8.3.6 Italy
8.3.7 Russia
9 Asia Pacific
9.1 Asia Pacific Enzalutamide API Market Size by Type
9.1.1 Asia Pacific Enzalutamide API Sales by Type (2017-2028)
9.1.2 Asia Pacific Enzalutamide API Revenue by Type (2017-2028)
9.2 Asia Pacific Enzalutamide API Market Size by Application
9.2.1 Asia Pacific Enzalutamide API Sales by Application (2017-2028)
9.2.2 Asia Pacific Enzalutamide API Revenue by Application (2017-2028)
9.3 Asia Pacific Enzalutamide API Sales by Region
9.3.1 Asia Pacific Enzalutamide API Sales by Region (2017-2028)
9.3.2 Asia Pacific Enzalutamide API Revenue by Region (2017-2028)
9.3.3 China
9.3.4 Japan
9.3.5 South Korea
9.3.6 India
9.3.7 Australia
9.3.8 Taiwan
9.3.9 Indonesia
9.3.10 Thailand
9.3.11 Malaysia
9.3.12 Philippines
10 Latin America
10.1 Latin America Enzalutamide API Market Size by Type
10.1.1 Latin America Enzalutamide API Sales by Type (2017-2028)
10.1.2 Latin America Enzalutamide API Revenue by Type (2017-2028)
10.2 Latin America Enzalutamide API Market Size by Application
10.2.1 Latin America Enzalutamide API Sales by Application (2017-2028)
10.2.2 Latin America Enzalutamide API Revenue by Application (2017-2028)
10.3 Latin America Enzalutamide API Sales by Country
10.3.1 Latin America Enzalutamide API Sales by Country (2017-2028)
10.3.2 Latin America Enzalutamide API Revenue by Country (2017-2028)
10.3.3 Mexico
10.3.4 Brazil
10.3.5 Argentina
11 Middle East and Africa
11.1 Middle East and Africa Enzalutamide API Market Size by Type
11.1.1 Middle East and Africa Enzalutamide API Sales by Type (2017-2028)
11.1.2 Middle East and Africa Enzalutamide API Revenue by Type (2017-2028)
11.2 Middle East and Africa Enzalutamide API Market Size by Application
11.2.1 Middle East and Africa Enzalutamide API Sales by Application (2017-2028)
11.2.2 Middle East and Africa Enzalutamide API Revenue by Application (2017-2028)
11.3 Middle East and Africa Enzalutamide API Sales by Country
11.3.1 Middle East and Africa Enzalutamide API Sales by Country (2017-2028)
11.3.2 Middle East and Africa Enzalutamide API Revenue by Country (2017-2028)
11.3.3 Turkey
11.3.4 Saudi Arabia
11.3.5 U.A.E
12 Corporate Profiles
12.1 Dr. Reddy?s Laboratories Ltd.
12.1.1 Dr. Reddy?s Laboratories Ltd. Corporation Information
12.1.2 Dr. Reddy?s Laboratories Ltd. Overview
12.1.3 Dr. Reddy?s Laboratories Ltd. Enzalutamide API Sales, Price, Revenue and Gross Margin (2017-2022)
12.1.4 Dr. Reddy?s Laboratories Ltd. Enzalutamide API Product Model Numbers, Pictures, Descriptions and Specifications
12.1.5 Dr. Reddy?s Laboratories Ltd. Recent Developments
12.2 Shilpa Medicare Limited
12.2.1 Shilpa Medicare Limited Corporation Information
12.2.2 Shilpa Medicare Limited Overview
12.2.3 Shilpa Medicare Limited Enzalutamide API Sales, Price, Revenue and Gross Margin (2017-2022)
12.2.4 Shilpa Medicare Limited Enzalutamide API Product Model Numbers, Pictures, Descriptions and Specifications
12.2.5 Shilpa Medicare Limited Recent Developments
12.3 ScinoPharm Taiwan, Ltd
12.3.1 ScinoPharm Taiwan, Ltd Corporation Information
12.3.2 ScinoPharm Taiwan, Ltd Overview
12.3.3 ScinoPharm Taiwan, Ltd Enzalutamide API Sales, Price, Revenue and Gross Margin (2017-2022)
12.3.4 ScinoPharm Taiwan, Ltd Enzalutamide API Product Model Numbers, Pictures, Descriptions and Specifications
12.3.5 ScinoPharm Taiwan, Ltd Recent Developments
12.4 Olon Spa
12.4.1 Olon Spa Corporation Information
12.4.2 Olon Spa Overview
12.4.3 Olon Spa Enzalutamide API Sales, Price, Revenue and Gross Margin (2017-2022)
12.4.4 Olon Spa Enzalutamide API Product Model Numbers, Pictures, Descriptions and Specifications
12.4.5 Olon Spa Recent Developments
12.5 Farmhispania, S.A.
12.5.1 Farmhispania, S.A. Corporation Information
12.5.2 Farmhispania, S.A. Overview
12.5.3 Farmhispania, S.A. Enzalutamide API Sales, Price, Revenue and Gross Margin (2017-2022)
12.5.4 Farmhispania, S.A. Enzalutamide API Product Model Numbers, Pictures, Descriptions and Specifications
12.5.5 Farmhispania, S.A. Recent Developments
12.6 Mac-Chem Products (India) Pvt.Ltd
12.6.1 Mac-Chem Products (India) Pvt.Ltd Corporation Information
12.6.2 Mac-Chem Products (India) Pvt.Ltd Overview
12.6.3 Mac-Chem Products (India) Pvt.Ltd Enzalutamide API Sales, Price, Revenue and Gross Margin (2017-2022)
12.6.4 Mac-Chem Products (India) Pvt.Ltd Enzalutamide API Product Model Numbers, Pictures, Descriptions and Specifications
12.6.5 Mac-Chem Products (India) Pvt.Ltd Recent Developments
12.7 Shandong Haohong Biotechnology
12.7.1 Shandong Haohong Biotechnology Corporation Information
12.7.2 Shandong Haohong Biotechnology Overview
12.7.3 Shandong Haohong Biotechnology Enzalutamide API Sales, Price, Revenue and Gross Margin (2017-2022)
12.7.4 Shandong Haohong Biotechnology Enzalutamide API Product Model Numbers, Pictures, Descriptions and Specifications
12.7.5 Shandong Haohong Biotechnology Recent Developments
13 Industry Chain and Sales Channels Analysis
13.1 Enzalutamide API Industry Chain Analysis
13.2 Enzalutamide API Key Raw Materials
13.2.1 Key Raw Materials
13.2.2 Raw Materials Key Suppliers
13.3 Enzalutamide API Production Mode & Process
13.4 Enzalutamide API Sales and Marketing
13.4.1 Enzalutamide API Sales Channels
13.4.2 Enzalutamide API Distributors
13.5 Enzalutamide API Customers
14 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
14.1 Enzalutamide API Industry Trends
14.2 Enzalutamide API Market Drivers
14.3 Enzalutamide API Market Challenges
14.4 Enzalutamide API Market Restraints
15 Key Finding in The Global Enzalutamide API Study
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
